Resonant Capital Advisors’s Colgate-Palmolive CL Stock Holding History

Resonant Capital Advisors’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$454K	Sell	4,949 -1,393	-22%	-$122K	0.02%	312
2026 Q1	$541K	Buy	6,342 +1,246	+24%	+$111K	0.03%	256
2025 Q4	$403K	Buy	+5,096	New	+$400K	0.02%	286
2025 Q3	–	Sell	-2,565	Closed	-$233K	–	442
2025 Q2	$233K	Buy	+2,565	New	+$234K	0.01%	380

Other funds holding CL

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Resonant Capital Advisors's CL Position: Q2 2026 in Review

Resonant Capital Advisors reduced its Colgate-Palmolive (CL) stake by 22% in Q2 2026, selling an estimated $122K and leaving 4,949 shares worth $454K. The position accounts for 0.02% of the portfolio, ranked #312.

Resonant Capital Advisors first reported a position in CL in Q2 2025 and has held it in 4 quarters since. The position peaked at $541K in Q1 2026. 1,167 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Resonant Capital Advisors held 4,949 shares of Colgate-Palmolive worth $454K as of Q2 2026.
Resonant Capital Advisors sold 1,393 Colgate-Palmolive shares in Q2 2026, an estimated $122K.
Colgate-Palmolive made up 0.02% of Resonant Capital Advisors's portfolio in Q2 2026, its #312 holding.
Resonant Capital Advisors first reported a position in Colgate-Palmolive in Q2 2025 and has held it in 4 quarters since.
Resonant Capital Advisors's Colgate-Palmolive position peaked at $541K in Q1 2026.
1,167 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.